The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study

Mark Liu,Florence Schleich,Jason Lee,Girolamo Pelaia,Carlos Almonacid Sanchez,Liam Heaney,Rafael Alfonso-Cristancho,Rupert Jakes,Robert Price,Aoife Maxwell,Peter Howarth

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2022）

引用 0|浏览21

暂无评分

摘要

Real-world data assessing clinical impact of mepolizumab according to baseline maintenance oral corticosteroids (mOCS) use is limited. We compared real-world outcomes in patients receiving mepolizumab stratified by baseline mOCS use.

查看译文

关键词

mepolizumab treatment,clinical benefit,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要